Skip to content
Open access

Single-cell RNA-seq and spatial transcriptomics characterize CD8+ exhausted T cells in pancreatic ductal adenocarcinoma

Jul 2026 · iScience · Vol 29, pp. 116934 · 0 citations · 65 references
Medicine

TL;DR

Low SPP1 and PLAUR expression correlated with poor prognosis in TCGA-PAAD and two key LR pairs mediated crosstalk between cancer cells and CD8+ Tex cells, confirmed by immunofluorescence, spatial mapping, and protein docking.

Abstract

Summary Pancreatic cancer resists immunotherapy due to a suppressive immune microenvironment where CD8+ T cells play a key role. Using single-cell RNA sequencing and spatial transcriptomics, we characterized CD8+ exhausted T (Tex) cells in pancreatic ductal adenocarcinoma (PDAC). We generated single-cell profiles from PDAC tumors and matched peripheral blood mononuclear cells, and performed T cell sub-analysis. We found CXCL13 upregulated and GZMK downregulated in CD8+ Tex cells. Cell-cell interaction analysis showed that T cells most frequently interacted with myeloid cells and cancer cells via ligand-receptor pairs; INHBA+ macrophages and cancer cells communicated most with CD8+ Tex cells. Two key LR pairs (SPP1-integrin α4β1 and PLAUR-integrin α4β1) mediated crosstalk between cancer cells and CD8+ Tex cells, confirmed by immunofluorescence, spatial mapping, and protein docking. High SPP1 and PLAUR expression correlated with poor prognosis in TCGA-PAAD. These findings provide a resource for understanding CD8+ T cell exhaustion in PDAC.

Read PDF

Similar papers

Open access Aug 2026

Integrative single-nucleus transcriptomic analysis identifies UBE2C+ proliferative tumor cells and immune-stromal regulatory crosstalk in small cell lung cancer

This study identified UBE2C+ proliferative tumor cells as a functionally relevant malignant subpopulation in SCLC and links this state to immune-stromal communication networks within the tumor microenvironment and provides a systems-level framework for investigating the cancer-immunity regulome in SCLC.

Hong-Ling Jia, Yongxuan An, Bing Chen et al. · 0 citations
Open access Aug 2026

Integrated Immunological Analysis of Interactions Between CXCL13+ T Cells and LAMP3+ DC in the Immunotherapy Response of Bladder Cancer.

The heterogeneity and interactions of CXCL13+ T cell/LAMP3+ DC subsets in bladder cancer TLS are delineated and DTscore is validated as a robust tool for predicting OS and immunotherapy response, offering a potential guide for personalized bladder cancer treatment.

Lin Zhou, Jinchao Zhu, Yushan Liu et al. · 0 citations
Open access Sep 2026

A CCL4-enriched NK-cell transcriptional state is associated with inflammatory and myeloid-stromal programs in colorectal cancer liver metastasis

CRLM is associated with altered NK-cell representation among recovered cells and a reproducible CCL4-enriched inflammatory NK-cell transcriptional state and its association with inflammatory and myeloid-stromal programs across independent, spatial and model-system analyses provides a focused framework for future lineag...

Li-Hong Lin, Michael Xu, Xiao-Chun Gu et al. · 0 citations
Open access Aug 2026

Single-cell RNA sequencing uncovers an immunosuppressive program in PDAC mast cells: tumour-driven activation, proliferation, and association with Treg recruitment

This study suggests that MCs are key orchestrators of immunosuppression in PDAC, predicted to interact with Tregs through the MIF–CD74/CXCR4 axis, offering a novel rationale for targeting the MC–Treg axis in future immunotherapeutic strategies.

Mengli Wu, Xuxia Ye, Qi Yu et al. · 0 citations
Review Jul 2026

Deciphering CD8+ T Cell Exhaustion in Human Cancers Through Single-Cell and Spatial Transcriptomics.

This review summarizes recent advances in high-resolution omics technologies for precisely dissecting Tex heterogeneity, functional features, and interactions with other cells, and emphasizes the central value of optimizing Tex-targeted tumor immunotherapy strategies.

Zi-Xuan Gou, Xiao-Jun Huang, Xiang-Yu Zhao · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.